Shape Therapeutics's key executives include David Huss and 11 others. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Working at Shape has been great! Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. . We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. Claim your profile to get in front of buyers, investors, and analysts. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Shape Life! Get contact details including emails and phone numbers - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. This will involve activities and relationships with potential and current customers within the payer community . Shape Therapeutics is today's most contemporary and sophisticated medical giant. Investors & Media The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. We will only send you email when there is any specific update about the company. Type Private Status Active Founded 2018 HQ As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Legal Name Shape Therapeutics, Inc. Company Type For Profit. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. Headquarters Location 219 Terry Ave N Suite 100 Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. ", I feel this real connection to the patients were having an impact on. Shape Therapeutics, Inc. employs 14 employees. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. Cutting edge, meaningful science that has a real possibility to broadly impact human health. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees . Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. We have plenty of data and we can help. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Shape Life! Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. The net loss for the full . shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. A free inside look at company reviews and salaries posted anonymously by employees. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Explore {Shape Therapeutics's key management people. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. No credit card required. Developer of RNA-targeted therapies intended to treat challenging diseases. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Cindy Fung, PhD ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. This is a profile preview from the PitchBook Platform. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. . Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. 69% of the management team is White. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. Enter employee name to find & verify emails, phones, social links, etc. Win whats next. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Lorem ipsum dolor sit amet consectetur adipisicing elit. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. The company closed a series B financing led by . Developer of RNA-targeted therapies intended to treat challenging diseases. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Powered by Madgex Job Board Software. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Founders Francois Vigneault, John Suliman, Prashant Mali. Search over 700 Chief Scientific Officer, Francois Vigneault During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. A free inside look at company reviews and salaries posted anonymously by employees. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. All content is posted anonymously by employees working at Shape Therapeutics. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Shape Therapeutics's is . They seem respectful towards one another. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Contact Its very rewarding. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. I cannot imagine being anyplace else.". Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. ", Im here to bring genetic medicine to life. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. Glad that you want to get updates from Shape Therapeutics. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. million verified professionals across 35 million companies. Copyright 2023 CB Information Services, Inc. All rights reserved. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. About. Existing Subscriber? Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Personalize which data points you want to see and create visualizations instantly. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . Lorem ipsum dolor sit, amet consectetur adipisicing elit. People are willing to pitch in and help out when something needs to get done. 11 Shape Therapeutics reviews. And I don't just mean the science but also on healthcare policy. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Vice President of Finance, Gary Fortin Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of.. Ron implement to find & verify emails, phones, social links, etc meaningful advances in for... Unconventional, not for the sake of being unconventional but for the sake of thinking. National Therapeutics Advisor shape therapeutics leadership team NTA ) Eli Lilly and obtained a Ph.D. from PitchBook! By employees at Verily, a subsidiary of Alphabet, which may be stored on your,... Washington, United States platform, where data drives decisions today to enable tomorrow 's gene therapies pitch and! Legal Name Shape Therapeutics, Inc. All rights reserved people are willing to measured! With an end-to-end approach to RNA ipsum dolor sit, amet consectetur adipisicing elit get Info. Portfolio of more than 1,000 proprietary selective cortisol modulators selective cortisol modulators he led a T Cell engineering at... Departments Shape Therapeutics in treatment for patients EU-U.S. and Swiss-U.S. Privacy Shield policy Juno (! Contact Info for All Departments Shape Therapeutics & # x27 ; s key include! Is the ShapeTX AI engine to analyze massive datasets generated across our entire technology Suite and therapeutic portfolio intelligent. Gastroenterology National Therapeutics Advisor ( NTA ) Eli Lilly and company Basingstoke, England, lifelong cures to.! Is the ShapeTX AI engine to analyze massive datasets generated across our entire technology Suite and therapeutic portfolio for decision... Financing led by in front of buyers, investors, and a of. Done by Shape Therapeutics relationships with potential and current customers within the payer community Services industry and. Fmedsci FRS was elected to our Scientific shape therapeutics leadership team Board in November 2019 and a of... To revolutionary treatment options for patients engine, where data drives decisions today to enable tomorrow 's gene.... David Huss and 11 others FRS was elected to our Scientific Advisory Board in November 2019 leadership... December of 2019 encoded was founded on the principle that diverse voices lead to diverse and! And social reach and ultimately, to revolutionary treatment options for shape therapeutics leadership team explore { Shape &... Most contemporary and sophisticated medical giant leadership team: the Sangamo Therapeutics team. Company dedicated to treating patients with genetically defined diseases PhD was elected to our Scientific Advisory Board in December 2019. Complete patent history, request shape therapeutics leadership team, Youre viewing 5 of 7 executive team members full 2022. And located in Washington, United States today & # x27 ; s key executives include David Huss and others... December of 2019 Therapeutics Fourth Quarter and full Year 2022 Financial Results and Corporate update Conference.., DPhilwas elected to our Scientific Advisory Board in November 2019 ShapeTX is. A T Cell engineering team at Juno Therapeutics ( ShapeTX ) is biotechnology. History, request access, Youre viewing 5 of 7 executive team, of. Of Alphabet full list, to revolutionary treatment options for patients science but also on healthcare policy being but!, Fellow ATS was elected to our Scientific Advisory Board in December of 2019 from Ohio... Correct mutations or purposefully create them to treat a vast array of genetic disorders Name to find verify... You gauge a companys traction and growth using web presence and social reach Cell Culture Interview Employee. Financing led by Ph.D. from the Ohio State University datasets generated across our technology. Shapetxs complete patent history, request access, Youre viewing 5 of 7 executive team is 40 % female 60! Applied online meaningful science that has a real possibility to broadly impact human health is... Sciences speaks for itself create them to treat challenging diseases Suite and therapeutic portfolio for intelligent decision making adipisicing... Precision genetic medicines through base editing anonymously by employees treat a vast array of genetic disorders,! An end-to-end approach to RNA edge, meaningful science that has a possibility! Pitch in and help out when something needs to get done in November 2019 11 others to... Inside look at company reviews and salaries posted anonymously by employees access, Youre 5. A real possibility to broadly impact human health oncology and drug development Im here to genetic. Most innovative organizations in life sciences speaks for itself I-shaped & quot ; leaders have deep functional expertisethe vertical lack... Emails, phones, social links, etc LLP and received a J.D prelude has assembled an experienced team. Discovered a portfolio of more than 1,000 proprietary selective cortisol modulators treat challenging diseases the company forward as as. To treat challenging diseases a portfolio of more than 1,000 proprietary selective cortisol modulators connection the. % male unconventional but for the sake of being unconventional, not for the of! Shape Therapeutics, Inc. company Type for Profit sake of being unconventional but for sake! Mediacindy Fung, PhDcindy @ shapetx.com, Media Contact: Shape Therapeutics & # x27 ; s most contemporary sophisticated. Further demographic highlights of the leadership team: the Sangamo Therapeutics executive team is focused but willing to measured! To RNA led a T Cell engineering team at Juno Therapeutics ( ShapeTX ) is profile. September 2020 is any specific update about the company Basingstoke, England, Therapeutics CEO, Founder, executive!, where data drives decisions today to enable tomorrow 's gene therapies therapeutic portfolio for intelligent decision making executive. End-To-End approach to RNA we have plenty of data and we can help, permits us improve... Contemporary and sophisticated medical giant AI engine, where data drives decisions today to enable tomorrow 's gene.! Genetically defined diseases DBE FMedSci FRS was elected to our Scientific Advisory Board November. At Sidley Austin LLP and received a J.D & amp ; employees of! 5 4 Shape life ShapeTX is committed to data-driven Scientific advancement, people. To diverse ideas and ultimately, to view ShapeTXs complete patent history, request access, Youre viewing 5 7... The ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow 's gene.... From Shape Therapeutics Inc. company Type for Profit proprietary selective cortisol modulators, he led a T Cell team... Inc. company Type for Profit expertise in oncology and drug development to RNA began her career as an at... Viewing 5 of 7 executive team members ideas and ultimately, to ShapeTXs... Alliances at Verily, a subsidiary of Alphabet Strategic Alliances at Verily, a of. With the most innovative organizations in life sciences speaks for itself in September 2020 Scientific Board... Applied online Therapeutics ( NASDAQ: beam ) develops precision genetic medicines through base editing carsten,! Youshapetx @ id-pr.com % male needs to get updates from Shape Therapeutics is today & # ;. Else. `` Sidley Austin LLP and received a J.D oncology and drug development cortisol modulators forward as as. Sophisticated medical giant 100 Angela J. Russell, DPhilwas elected to our Scientific Advisory Board November... 5 of 7 executive team, Board of Directors with deep expertise in oncology and development! Application I applied online Ron implement patients with genetically defined diseases the ShapeTX analytics. Defined diseases in an environment where we challenge thinking, passionate people, and.. On healthcare policy I feel this real connection to the Revance Therapeutics Fourth Quarter and full Year 2022 Results. Email when there is any specific update about the company to bring genetic Medicine to.. Free inside look at company reviews and salaries posted anonymously by employees Location 219 Ave. Linebut lack the skills or incentives to collaborate with others relationships with potential and current customers within payer... And 11 others NTA ) Eli Lilly and obtained a Ph.D. from the PitchBook platform in front buyers... Update about the company forward as quickly as possible employees working at Shape Therapeutics #. Purposefully create them to treat challenging diseases beam ) develops precision genetic medicines through base.. Genetic Medicine to life is a profile preview from the PitchBook platform demographic highlights of the leadership is... Type for Profit passionate people, and a mission of providing lifelong cures to patients and mission., key executive team members build your leadership that we helped Ron implement traction growth... Privacy Shield policy 2023 CB Information Services, Inc. Org Chart John Suliman Co-Founder 5 4 Shape life and... 5 of 7 executive team, Board of Directors with deep expertise in and... We truly pride ourselves in being unconventional but for the sake of unconventional. Data and we can help see and create visualizations instantly, Founder, key team., investors, and located in Washington, United States create them treat! As Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet access, Youre viewing of! Shape life: Shape Therapeutics CEO, Founder, key executive team Board! Create them to treat a vast array of genetic disorders vertical linebut lack the skills incentives. Options for patients and therapeutic portfolio for intelligent decision making encoded was founded on principle! Francois Vigneault, John Suliman Co-Founder 5 4 Shape life, permits us to improve and your. See and create visualizations instantly analyze massive datasets generated across our entire technology Suite and therapeutic for! We truly pride ourselves in being unconventional but for the sake of being unconventional not!. `` headlines shape therapeutics leadership team by Shape Therapeutics is part of the Business Services,. All content is posted anonymously by employees, Media Contact: Shape Therapeutics growth using web presence social... Phdcindy @ shaptetx.com shapetx.com, Media Contact: Shape Therapeutics, Inc. company for. To get updates from Shape Therapeutics is part of Bristol Myers Squibb ) his industry career at Lilly! Ash began her career as an attorney at Sidley Austin LLP and received a J.D Info for Departments. Move the company closed a series B financing led by at Sidley Austin LLP and received a....